Clear Search
AMA members address HOD during 2019 Annual Meeting
·
3 MIN READ

Time to scrutinize PBMs’ outsized role in Rx decision-making

The AMA calls for transparency and oversight of pharmacy benefit managers’ (PBM) operations.

Public Health
·
7 MIN READ

May 31, 2019: National Advocacy Update

Surprise billing proposals in Congress, Part D and Medicare Advantage drug pricing and more in the latest AMA national health care advocacy news.

Advocacy Update
·
8 MIN READ

May 18, 2019: National Advocacy Update

Federal Pain Task Force, prices in drug ads and more in the latest AMA national health care advocacy news.

Advocacy Update
A woman holding a credit card while using a laptop
·
4 MIN READ

AMA to Congress: Patients pay painful price for high drug costs

AMA leader tells of a patient who relies on an older drug that rose in price by 400% to about $80,000 a year. Share your stories to advance drug-pricing transparency.

Public Health
·
1 MIN READ

AMA: Trump administration requiring pricing information in TV drug ads

The Trump Administration has taken a step in the right direction requiring pricing information in television advertising of prescription drugs.

Press Releases
1 MIN READ

The truth behind drug prescription pricing

Spending on prescription drugs is on the rise in the United States, but lack of oversight on drug pricing offers no answers for price fluctuations.

Public Health
·
6 MIN READ

April 18, 2019: National Advocacy Update

Causes of surprise billing, ambulatory blood pressure monitoring and more in the latest AMA national health care advocacy news.

Advocacy Update
·
1 MIN READ

AMA applauds congressional action on prescription drug transparency

The AMA believes in transparency in prescription drug pricing, and we are pleased the House Ways & Means Committee moved the issue forward.

Press Releases
Graphic image of pill bottles with different money signs on them.
·
3 MIN READ

How are prescription drug prices determined?

Congress has put drug prices under its microscope. The scrutiny is new, but the conversation is the same: Drugmakers, pharmacy benefit managers and payers set prices but never explain how.

Public Health